Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-08-09
2005-08-09
Weber, Jon (Department: 1653)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S003100, C514S012200, C530S303000, C530S387200, C530S388200, C435S069400, C435S810000, C424S131100, C424S145100
Reexamination Certificate
active
06927204
ABSTRACT:
Compositions, methods, and devices are provided for inducing or enhancing the growth, proliferation, regeneration of inner ear tissue, particularly inner ear hair cells. In addition, provided are compositions and methods for prophylactic or therapeutic treatment of a mammal afflicted with an inner ear disorder or condition, particularly for hearing impairments involving hair cell damage, loss, or degeneration, by administration of a therapeutically effective amount of IGF-1 or FGF-2, or their agonists, alone or in combination.
REFERENCES:
patent: 3773919 (1973-11-01), Boswell
patent: 4485045 (1984-11-01), Regen
patent: 4544545 (1985-10-01), Ryan et al.
patent: 4637402 (1987-01-01), Adelman
patent: 4892538 (1990-01-01), Aebischer et al.
patent: 5011472 (1991-04-01), Aebischer et al.
patent: 5077276 (1991-12-01), Ballard et al.
patent: 5164370 (1992-11-01), Ballard et al.
patent: 5187151 (1993-02-01), Clark et al.
patent: 5229271 (1993-07-01), Philpott
patent: 5352589 (1994-10-01), Bergonzoni et al.
patent: 5407913 (1995-04-01), Sommer et al.
patent: 5464943 (1995-11-01), Senoo et al.
patent: 5470828 (1995-11-01), Ballard et al.
patent: 5482929 (1996-01-01), Fukunaga et al.
patent: 5514566 (1996-05-01), Fiddes et al.
patent: 5546956 (1996-08-01), Thornton
patent: 5843749 (1998-12-01), Maisonpierre et al.
patent: 6133231 (2000-10-01), Ferrara et al.
patent: 6136785 (2000-10-01), Corwin et al.
patent: 6156728 (2000-12-01), Gas
patent: 6653279 (2003-11-01), Gao
patent: 3218121 (1983-11-01), None
patent: 36676 (1981-09-01), None
patent: 52322 (1982-05-01), None
patent: 58481 (1982-08-01), None
patent: 88046 (1983-09-01), None
patent: 102324 (1984-03-01), None
patent: 128733 (1984-12-01), None
patent: 142641 (1985-05-01), None
patent: 143949 (1985-06-01), None
patent: 230869 (1987-08-01), None
patent: 288451 (1988-10-01), None
patent: 60-007934 (1985-01-01), None
patent: WO 87/01038 (1987-02-01), None
patent: WO 92/19195 (1992-11-01), None
patent: WO 93/10810 (1993-06-01), None
patent: WO 94/04030 (1994-03-01), None
patent: WO 95/05452 (1995-02-01), None
Low, W., et al., “Basic Fibroblast Growth Factor (FGF-2) Protects Rat Cochlear Hair Cells in Organotypical Culture From Aminoglycoside Injury”,Journal of Cellular Physiology—167(3):445-450 (1996).
Ernfors et al., “Protection of auditory neurons from aminoglycoside toxicity by neurotrophin-3”, Nature Medicine, vol. 2, No. 4, pp. 463-467, Apr. 1996.
Staecker et al., “NT-3 combined with CNTF promotes survival of neurons in modioluis-spiral ganglion explants”, NeuroReport vol. 6, No. 11, pp. 1533-1537, Jul. 1995.
Acheson et al., “A BDNF autocrine loop in adult sensory neurons prevents cell death”Nature374:450-453 (1995).
Adler et al., “Immunocytochemical Evidence for Supporting Cell Conversion in the Acoustically Damaged Chick”Assoc. Research Otolaryngology(Abstract 16) pps. 4 (Feb. Meeting 1996).
Anderson, D. J., “The Neural Crest Cell Lineage Problem: Neuropolesis?”Neuron3:1-12 (Jul. 1989).
Anniko et al., “Cisplatin: Evaluation of its Ototoxic Potential”Am. J. Otolaryngol.7:276-293 (1986).
Apfel et al., “Nerve Growth Factor Prevents Toxic Neuropathy in Mice”Annals of Neurology29(1):87-90 (Jan. 1991).
Ard et al., “Trophic Interactions Between the Cochleovestibular Ganglion of the Chick Embryo and its Synaptic Targets in Culture”Neuroscience16(1):151-170 (1985).
Au et al., “Aminoglycoside Antibiotics Preferentially Increase Permeability in Phosphoinositide-containing Membranes: a Study with Carboxyfluoroscein in Liposomes”Biochimica et Biophysica Acta902:80-86 (1987).
Baird et al., “Cerebellar Target Neurons Provide a Stop Signal for Afferent Neurite Extension in vitro”The Journal of Neuroscience12(2):619-634 (Feb. 1992).
Balak et al., “Regenerated hair cells can originate from supporting cell progeny: evidence from phototoxicity and laser ablation experiments in the lateral line system”J. Neurosci10:2502-2512 (1990).
Barbacid, “The Trk Family of Neurotrophin Receptors: Molecular Characterization and Oncogenic Activation in Human Tumors”Molecular Genetics of Nervous System Tumorspps. 123-136 (1993).
Barde et al., “Purification of a New Neurotrophic Factor From Mammalian Brain”EMBO Journal1(5):549-553 (1982).
Bareggi et al., “Gentamicin Ototoxicity: Histological and Ultrastructural Alterations After Transtympanic Administration”Pharmacological Research22(5):635-644 (1990).
Barker et al., “Disruption of NGF Binding to the Low Affinity Neurotrophin Receptor p75LNTRReduces NGF Binding to TrkA on PC12 Cells”Neuron13:203-215 (1994).
Beck et al., “Igf1 Gene Disruption Results in Reduced Brain Size. CNS Hypomyelination. and Hippocampal Granule and Striatal Parvalbumin-Containing Neurons”Neuron14:717-730 (Apr. 1995).
Berggren et al., “Intermediate Filament Proteins in the Embryonic Inner Ear of Mice Under Normal Conditions and After Exposure to Ototoxic Drugs”Acta Otolaryngol109:57-65 (1990).
Berkemeier et al., “Neurotrophin-5: A Novel Neurotrophic Factor That Activates trk and trkB”Neuron7:857-866 (Nov. 1991).
Bianchi et al., “Development of Auditory and Vestibular Neurons in Mice with a Targeted Disruption of the BDNF or NT-4 Gene”Assoc. Research Otolaryngology(Abstract 429) pps. 108 (Feb. Meeting 1996).
Boettcher et al., “Concentration of Salicylate in Serum and Perilymph of the Chinchilla”Arch Otolaryngol Head Neck Surg.116:681-684 (1990).
Boettcher et al., “Effects of Sodium Salicylate on Evoked-response Measures of Hearing”Hearing Research42:129-142 (1989).
Boettcher et al., “Salicylate Ototoxicity: Review and Synthesis”Am. J. Otolaryngol.12:33-47 (1991).
Carenza et al., “Peripheral Neuropathy and Ototoxicity of Diclorodiamineplatinum: Instrumental Evaluation”Gynecologic Oncology25:244-249 (1986).
Cattaneo et al., “Proliferation and Differentiation of Neuronal Stem Cells Regulated by Nerve Growth Factor”Nature347:762-765 (1990).
Chao, “Gene Transfer and Molecular Cloning of the Human NGF Receptor”Science232:518-521 (1986).
Chao, “Growth Factor Signaling: Where is the Specificity?”Cell68:995-997 (Mar. 20, 1992).
Clary et al., “An Alternatively Spliced Form of the Nerve Growth Factor Receptor TrkA Confers an Enhanced Response to Neurotrophin 3”Proc. Natl. Acad. Sci. USA91:11133-11137 (1994).
Clary et al., “TrkA Cross-linking Mimics Neuronal Responses to Nerve Growth Factor”Molecular Biology of the Cell5:549-563 (1994).
Cohen et al., “Neurotrophin-4/5 (NT-4/5) Increases Adult Rat Retinal Ganglion Cell Survival and Neurite Outgrowth in vitro”Journal of Neurobiology25(8):953-959 (1994).
Cordon-Cardo et al., “The trk Tyrosine Protein Kinase Mediates the Mitogenic Properties of Nerve Growth Factor and Neurotrophin-3”Cell66:173-183 (Jul. 12, 1991).
Corwin et al., “Auditory Hair Cells: Structure, Function, Development, and Regeneration”Annu. Rev. Neuroscience14:301-333 (1991).
Corwin et al., “Isolation of Pure Living Hair Cell Epithelia by Use of Thermolysin”Assoc. Research Otolaryngology(Abstract 345) pps. 87 (Feb. Meeting 1996).
Corwin et al., “Regeneration of Sensory Hair Cells After Acoustic Trauma”Science240:1772-1774 (Jun. 24, 1988).
Cotanche et al., “Regeneration of Hair Cell Stereociliary Bundles in the Chick Cochlea Following Severe Acoustic Trauma”Hearing Research30:181-196 (1987).
Cotanche et al., “Regeneration of Hair Cells in the Vestibulocochlear System of Birds and Mammals”Current Opinion in Neurobiology4:509-514 (1994).
Davies et al., “Different Factors From the Central Nervous System and Periphery Regulate the Survival of Sensory Neurones”Nature319:497-449 (1986).
Davies et al., “Neurotrophin-4/5 Is a Mammalia
Dreger Ginger R.
Fox James A.
Genentech Inc.
Heller Ehrman White & McAuliffe LLP
Mohamed Abdel A.
LandOfFree
Treatment of inner ear hair cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of inner ear hair cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of inner ear hair cells will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3523147